Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |